Dr Reddy s Resof-L Tablets

15,000.00

We are the leading exporters of Resof L (Ledipasvir 90mg + Sofosbuvir 400mg) tablet and other Hepatitis C medicines like Rifugut 550, Sofocure L, Cimivir L, Hepcinat Plus, Virso Tablets and many more.

Description –

Resof L tablet (Ledipasvir 90mg + Sofosbuvir 400mg) is a Hepatitis C virus medication. Resof L contains Ledipasvir 90mg + Sofosbuvir 400mg. Resof L is available in the form of Tablets. Manufacturer & Marketed company name of this tablet is Dr. Reddy Ltd.

This medicine is used in the treatment of chronic hepatitis C virus (HCV) infection. It fights against the viruses to resolve the infection.

Used for-

Resof L is used in the treatment of Hepatitis C. Resof L tablet is a combination of two antiviral drugs Sofosbuvir and Ledipasvir. This medicine is used in the treatment of chronic Hepatitis C virus (HCV). It works by blocking the action of a specific protein and preventing its spread in the body.

Category: Tag: Brands:

Description

We are the leading exporters of Resof L (Ledipasvir 90mg + Sofosbuvir 400mg) tablet and other Hepatitis C medicines like Rifugut 550, Sofocure L, Cimivir L, Hepcinat Plus, Virso Tablets and many more.

Description –

Resof L tablet (Ledipasvir 90mg + Sofosbuvir 400mg) is a Hepatitis C virus medication. Resof L contains Ledipasvir 90mg + Sofosbuvir 400mg. Resof L is available in the form of Tablets. Manufacturer & Marketed company name of this tablet is Dr. Reddy Ltd.

This medicine is used in the treatment of chronic hepatitis C virus (HCV) infection. It fights against the viruses to resolve the infection.

Used for-

Resof L is used in the treatment of Hepatitis C. Resof L tablet is a combination of two antiviral drugs Sofosbuvir and Ledipasvir. This medicine is used in the treatment of chronic Hepatitis C virus (HCV). It works by blocking the action of a specific protein and preventing its spread in the body.

Reviews

There are no reviews yet.

Be the first to review “Dr Reddy s Resof-L Tablets”

Your email address will not be published. Required fields are marked *